Rentschler Biopharma announces largest single investment in the higher double-digit range at its headquarters in Germany for construction of a new buffer media facility in Laupheim.
https://european-biotechnology.com/wp-content/uploads/2024/11/Rentschler-Biopharma_150516_0186_Nukleus.jpg540960Georg Kääb/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngGeorg Kääb2024-10-24 07:30:102024-10-24 07:49:09Rentschler with double-digit investment in Germany